Immatics N.V. (IMTX) Social Stream
IMMATICS NV (IMTX) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering IMTX.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
Over the past 15 months, IMTX's average price target has gone down $3.77.
IMTX reports an average of 129.92% for its upside potential over the past 46 weeks.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
IMTX Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
IMTX's average broker recommendation rating improved by 0.2 over the prior 16 months.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for IMTX as an investment opportunity.
- IMMATICS NV's number of analysts covering the stock is greater than 124.4% of all US stocks.
- IMMATICS NV's upside potential (average analyst target price relative to current price) is greater than 666.26% of all US stocks.
- IMMATICS NV's average analyst price target is greater than 221.79% of all US stocks.
- To contextualize these metrics, consider that out of stocks in the small market cap category, IMMATICS NV's variance in analysts' estimates is lower than -423.59% of them.
Stocks similar to IMMATICS NV in the Pharmaceutical Products industry regarding analyst recommendations and price targets are GRTS, STRO, and AUTL.
View All Top Stocks by Price Target
Is IMTX a Buy, Hold or Sell? See the POWR Ratings now!